Systems and methods for platform agnostic whole body image segmentation
Inventors
Richter, Jens Filip Andreas • Johnsson, Kerstin Elsa Maria • Gjertsson, Erik Konrad • Anand, Aseem Undvall
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Presented herein are systems and methods that provide for automated analysis of three-dimensional (3D) medical images of a subject in order to automatically identify specific 3D volumes within the 3D images that correspond to specific anatomical regions (e.g., organs and/or tissue). Notably, the image analysis approaches described herein are not limited to a single particular organ or portion of the body. Instead, they are robust and widely applicable, providing for consistent, efficient, and accurate detection of anatomical regions, including soft tissue organs, in the entire body. In certain embodiments, the accurate identification of one or more such volumes is used to automatically determine quantitative metrics that represent uptake of radiopharmaceuticals in particular organs and/or tissue regions. These uptake metrics can be used to assess disease state in a subject, determine a prognosis for a subject, and/or determine efficacy of a treatment modality.
Core Innovation
The invention provides a system for automatically segmenting a first group of tissue regions depicted within a 3D anatomical image of a subject. The system receives the 3D anatomical image and segments it using a selected trained machine learning module from a set of trained machine learning modules to produce a 3D segmentation map identifying corresponding 3D volumes.
The system receives a 3D functional image obtained following administration of a radiopharmaceutical comprising a prostate-specific membrane antigen (PSMA) binding agent. The system transfers the 3D segmentation map to the 3D functional image to identify a second plurality of 3D volumes corresponding to the first plurality of 3D volumes, and detects hotspots representing cancerous lesions within the 3D functional image using the identified second plurality of 3D volumes.
In embodiments directed to pelvic or abdomen regions, the system identifies a volume of interest (VOI) for the pelvic region or abdomen, segments within that VOI using a region-specific trained machine learning module, and performs hotspot detection within the identified functional volumes. The pelvic region module is trained to identify members consisting of left ilium, right ilium, prostate, urinary bladder, sacrum, and coccyx, and the abdomen module is trained to identify members consisting of liver, left kidney, right kidney, and gallbladder.
Claims Coverage
The independent-claim coverage includes three inventive features. Collectively, they cover automated 3D anatomical segmentation with trained machine learning modules, transfer of the segmentation to PSMA radiopharmaceutical functional images, and detection of hotspots representing cancerous lesions, with additional pelvic and abdomen region limitations.
Automatic segmentation and hotspot detection using PSMA functional imaging
Receive a 3D anatomical image, segment the 3D anatomical image using a selected trained machine learning module from a set of trained machine learning modules to produce a 3D segmentation map identifying a first plurality of 3D volumes corresponding to a first group of tissue regions, receive a 3D functional image obtained following administration of a radiopharmaceutical comprising a PSMA binding agent, transfer the 3D segmentation map to the 3D functional image to identify a second plurality of 3D volumes corresponding to the first plurality of 3D volumes, and detect hotspots representing cancerous lesions within the 3D functional image using the identified second plurality of 3D volumes.
Pelvic-region VOI segmentation with PSMA functional hotspot detection
Receive a 3D anatomical image, identify within the 3D anatomical image a volume of interest corresponding to the pelvic region, segment the 3D anatomical image using a pelvic region module selected from a set of trained machine learning modules to produce a 3D segmentation map identifying a plurality of 3D volumes corresponding to a group of tissue regions within the pelvic region, receive a 3D functional image obtained following administration of a radiopharmaceutical comprising a PSMA binding agent, transfer the 3D segmentation map to the 3D functional image, and detect hotspots representing cancerous lesions within the identified second plurality of 3D volumes.
Abdomen-region VOI segmentation with PSMA functional hotspot detection
Receive a 3D anatomical image, identify within the 3D anatomical image a volume of interest corresponding to the abdomen, segment the 3D anatomical image using an abdomen module selected from a set of trained machine learning modules to produce a 3D segmentation map identifying a plurality of 3D volumes corresponding to a group of tissue regions within the abdomen, receive a 3D functional image obtained following administration of a radiopharmaceutical comprising a PSMA binding agent, transfer the 3D segmentation map to the 3D functional image, and detect hotspots representing cancerous lesions within the identified second plurality of 3D volumes.
The independent claims cover automated segmentation of 3D tissue regions using selected trained machine learning modules, alignment of those segmented volumes to PSMA radiopharmaceutical 3D functional images by transferring the segmentation map, and detection of cancerous-lesion hotspots within the functional volumes.
Stated Advantages
Documented Applications
No documented applications found
Interested in licensing this patent?